TrialJournal of hypertension2018

A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension.

William C Cushman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.